
News|Articles|August 30, 2023
CPAN Advocacy Chat – What to Know About Open Enrollment
Advertisement
On Wednesday, September 13, 2023, at 12:00pm ET, join COA’s Director of Patient Advocacy and Education Rose Gerber, MS, for a conversation with Kathy Oubre, CEO of Pontchartrain Cancer Center in Louisiana. Kathy will share her experiences counseling patients on what to look for in a good plan and how to overcome typical challenges encountered during the sign-up process.
This event will be part of our virtual CPAN Advocacy Chats series - monthly, 30-minute, educational webinars on key cancer issues and the policies that impact them. Each month features a new topic and special guest joining us. Patients, survivors, caregivers, and other cancer care advocates are all invited to join us for these free, interactive, virtual events!
Advertisement
Related to this article

An expert from Case Western Reserve University explains how cancer cells survive treatment, why rare diseases are hard to study and why CAR-T therapy offers hope.

The FDA approved Wilserdly with everolimus for some ER-positive, HER2-negative, ESR1-mutated advanced breast cancers that grew after prior hormone therapy.

An updated ASTRO guideline released Oct. 27, 2026, says most men getting radiation for prostate cancer that has not spread can safely finish treatment in weeks instead of months, and many can finish in five sessions. Here is what that means for patients.

Food safety, germs, fatigue, taste changes and tough questions can make Thanksgiving harder during cancer treatment. Here are five ways to plan ahead.

City of Hope experts share integrative therapies that may ease breast cancer side effects such as joint pain, hot flashes, poor sleep, fatigue and anxiety.

In a secondary analysis of a phase 3 trial published Nov. 13, 2026, people with locally advanced pancreatic cancer who wore the Optune Pax device with chemotherapy went about three months longer before their pain worsened than those who had chemotherapy alone.

City of Hope experts explain integrative oncology in breast cancer: when to consider it, why it won't replace treatment and what to know about supplements.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Wilserdly Combo for ESR1-Mutated Breast Cancer
2
5 Ways to Cope With Scanxiety While Waiting for Cancer Results
3
Breast Cancer Side Effects: Integrative Therapies That May Help
4
Integrative Oncology and Breast Cancer: What Patients Should Know
5

